Vogliter M 500mg/0.2mg Tablet SR
Marketer
Zeelab Pharmacy Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Vogliter M 500mg/0.2mg Tablet SR
Diabetic patients (adults) utilize Vogliter M 500mg/0.2mg SR tablets, an anti-diabetic medication combining two drugs to manage type 2 diabetes mellitus. This dual-action formulation regulates blood glucose levels. Administer Vogliter M with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar; abrupt cessation increases the risk of complications including kidney problems, vision loss, neuropathy, and limb loss. Remember, Vogliter M is one component of a comprehensive diabetes management plan incorporating diet, exercise, and weight control as recommended by your doctor. Lifestyle significantly impacts diabetes control. Potential side effects – nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions – are usually transient. Persistent or concerning side effects warrant medical consultation. Your doctor can offer management strategies. Vogliter M is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women must consult their doctor before use. Regular blood glucose monitoring and potential blood tests (blood cell counts and liver function) are recommended by your doctor.
Uses of Vogliter M 500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Vogliter M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vogliter M 500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Vogliter M 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Vogliter M 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vogliter M 500mg/0.2mg Tablet SR whole; do not chew, pulverize, or fracture it. Administer this extended-release tablet with a meal.
How Vogliter M 500mg/0.2mg Tablet SR works:
Vogliter M 500mg/0.2mg extended-release tablets contain a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogliter M 500mg/0.2mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Vogliter M 500mg/0.2mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vogliter M 500mg/0.2mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Extended-release Vogliter M 500mg/0.2mg tablets typically do not impair driving ability. Nevertheless, individuals taking this medication concurrently with other diabetes treatments like sulfonylureas, insulin, or repaglinide should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Vogliter M 500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Vogliter M 500mg/0.2mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vogliter M 500mg/0.2mg Tablet SR :
Should you forget a dose of Vogliter M 500mg/0.2mg sustained-release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogliter M 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently